ScienceDaily (Feb. 13, 2009) — VIB scientists connected to the Center for Human Heredity have demonstrated that a particular protein is extremely well suited to be a target for a new medicine against Alzheimer's disease. Their findings are published in the journal Science.
collaboration with Galapagos, the biotechnology company that discovered the protein's role in Alzheimer's disease and that will now further the search for an appropriate medicine.
Two thirds of all patients with dementia suffer from Alzheimer's disease. Alzheimer's is a disease that gradually destroys brain cells, with the result that the mental capacity of patients with Alzheimer's gradually declines. At first, memory begins to fail, but the patient's cognitive capabilities also deteriorate as the disease progresses.
Today, this disease cannot yet be cured. Current medicines for Alzheimer's patients sustain the memory functions for a short time, but they are unable to stop.....read the rest of the article
For more dementia information, click here
For Alzheimer's and dementia activities, click here
For learning how to be a better caregiver, click here
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment